Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship

Gynecologic Oncology

Volumn 114, Issue 1, 2009, Pages 121-127

  Fader, Amanda Nickles ^a,b,c   Arriba, Lucybeth Nieves ^a,b,c   Frasure, Heidi E ^a,b,c   von Gruenigen, Vivian E ^a,b,c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Biomarkers; Endometrial cancer; Epidemiology; Obesity; Prevention; Quality of life

Indexed keywords

ADIPONECTIN; ANDROGEN; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; ESTROGEN; GLUCOSE; INSULIN; LECTIN; PROLACTIN; SOMATOMEDIN C; THYROTROPIN;

CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYSTERECTOMY; LAPAROSCOPY; LAPAROTOMY; LIFESTYLE MODIFICATION; MORBID OBESITY; MORBIDITY; MORTALITY; OBESITY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SCREENING TEST; TREND STUDY; UNITED STATES;

ANDROGENS; CELL DIVISION; DIABETES MELLITUS, TYPE 2; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; HUMANS; INSULIN; OBESITY, MORBID; OVARY; PROLACTIN; SURVIVAL RATE; SURVIVORS; THYROTROPIN; TUMOR MARKERS, BIOLOGICAL;

EID: 67349141286     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.03.039     Document Type: Review

References (56)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2008. CA. Cancer J. Clin. 58 (2008) 71-96
2. Rose S.L., Bradley S.L., Lutgendorf S.K., Sorosky J., and Anderson B. The impact of adjuvant radiation therapy on long-term quality of life in patients with stage I endometrial cancer. Gynecol. Oncol. 92 (2004) 479-480
3. von Gruenigen V.E., Gil K.M., Frasure H.E., Jenison E.J., and Hopkins M.P. The impact of obesity and age on quality of life in gynecologic surgery. Am. J. Obstet. Gynecol. 193 (2005) 1369-1375
4. Jemal A., Thomas A., Murray T., and Thun M. Cancer statistics, 2002. CA. Cancer J. Clin. 52 (2002) 23-47
5. von Gruenigen V., Tian C., Frasure H., Waggoner S., and Barakat R. Treatment toxicity, disease recurrence and survival as related to obesity in women with early endometrial carcinoma: a Gynecologic Oncology Group study. Cancer 107 (2006) 2786-2791
6. Chia V.M., Newcomb P.A., Trentham-Dietz A., and Hampton J.M. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int. J. Gynecol. Cancer 17 (2007) 441-446
7. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348 (2003) 1625-1638
8. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
9. Sjöström L., Narbro K., Sjöström C.D., Karason K., Larsson B., Wedel H., et al., Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med. 357 (2007) 741-752
10. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
11. Calle E.E., and Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4 (2004) 579-591
12. Hossain P., Kawar B., and el Nahas M. Obesity and diabetes in the developing world-a growing challenge. N. Engl. J. Med. 356 (2007) 213-215
13. Abu-Abid S., Szold A., and Klausner J. Obesity and cancer. J. Med. 33 (2002) 73-86
14. Schouten L.J., Goldbohm R.A., and van den Brandt P.A. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J. Natl. Cancer Inst. 96 (2004) 1635-1638
15. Soliman P.T., Oh J.C., Schmeler K.M., Sun C.C., Slomovitz B.M., Gershenson D.M., et al. Risk factors for young premenopausal women with endometrial cancer. Obstet. Gynecol. 105 (2005) 575-580
16. Kaaks R., Lukanova A., and Kurzer M.S. Obesity, endogenous hormones, and endometrial cancer risk: a systematic review. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 1531-1543
17. Siiteri P.K. Steroid hormones and endometrial cancer. Cancer Res. 38 (1978) 4360-4366
18. Key T.J., and Pike M.C. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br. J. Cancer 57 (1988) 205-212
19. Chen L.M., and Berek J. Endometrial cancer: recent developments in evaluation and treatment. Oncology 13 (1999) 1665-1670
20. Potischman N., Hoover R.N., Brinton L.A., Siiteri P., Dorgan J.F., and Swanson C.A. Case-control study of endogenous steroid hormones and endometrial cancer. J. Natl. Cancer Inst. 88 (1996) 1127-1135
21. Ito K., Utsunomiya H., Yaegashi N., and Sasano H. Biological roles of estrogen and progesterone in human endometrial carcinoma-new developments in potential endocrine therapy for endometrial cancer. Endocr. J. 54 (2007) 667-679
22. Lacey Jr. J.V., Ioffe O.B., Ronnett B.M., Rush B.B., Richesson D.A., Chatterjee N., et al. Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan. Br. J. Cancer 98 (2008) 45-53
23. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 275 (1996) 370-375
24. O'Mara B.A., Byers T., and Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J. Chronic. Dis. 38 (1985) 435-441
25. Adami H.O., McLaughlin J., Ekbom A., Berne C., Silverman D., Hacker D., et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2 (1991) 307-314
26. Talavera F., Reynolds R.K., Roberts J.A., and Menon K.M. Insulin-like growth factor I receptors in normal and neoplastic human endometrium. Cancer Res. 50 (1990) 3019-3024
27. Cong L., Gasser J., Zhao J., Yang B., Li F., and Zhao A.Z. Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Endocr. Relat. Cancer 14 (2007) 713-720
28. Soliman P.T., Wu D., Tortolero-Luna G., Schmeler K.M., Slomovitz B.M., Bray M.S., et al. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106 (2006) 2376-2381
29. Cust A.E., Kaaks R., Friedenreich C., Bonnet F., Laville M., Tjønneland A., et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr. Relat. Cancer 14 (2007) 755-767
30. Sharma D., Saxena N.K., Vertino P.M., and Anania F.A. Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr. Relat. Cancer 13 (2006) 629-640
31. Cymbaluk L., Chudecka-Głaz A., and Rzepka-Górska I. Leptin levels in serum depending on body mass index in patients with endometrial hyperplasia and cancer. Eur. J. Obstet. Gynecol. Reprod. Biol. 136 (2008) 74-77
32. Yurkovetsky Z., Ta'asan S., Skates S., Rand A., Lomakin A., Linkov F., et al. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin. Gynecol. Oncol. 107 (2007) 58-65
33. Havrilesky LJ, Maxwell G, Myers ER. Cost effectiveness of annual screening strategies for endometrial cancer. Gynecol Oncol 2008;08(Suppl 1):S7.
34. R.A. Smith, A.C. von Eschenbach, R. Wender, et al. American Cancer Society Guidelines for Early Endometrial Cancer Detection: Update 2001.
35. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Weight Control and Physical Activity; International Agency for Research on Cancer, Lyon, 2002.
36. Ballard-Barbash R., and Swanson C.A. Body weight: estimation of risk for breast and endometrial cancer. Am. J. Clin. Nutr. 63 (1996) 437-441
37. Patel A.V., Feigelson H.S., Talbot J.T., McCullough M.L., Rodriguez C., Patel R.C., et al. The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women. Int. J. Cancer 123 (2008) 1877-1882
38. Rock C.L., and Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J. Clin. Oncol. 20 (2002) 3302-3316
39. Bravi F., Scotti L., Bosetti C., Zucchetto A., Talamini R., Montella M., Greggi S., Pelucchi C., Negri E., Franceschi S., and La Vecchia C. Food groups and endometrial cancer risk: a case-control study from Italy. Am. J. Obstet. Gynecol. 200 3 (2009 Mar) 293.e1-293.e7
40. Soliman P.T., Bassett Jr. R.L., Wilson E.B., Boyd-Rogers S., Schmeler K.M., Milam M.R., et al. Limited public knowledge of obesity and endometrial cancer risk: what women know. Obstet. Gynecol. 112 (2008) 835-842
41. Everett E., Tamimi H., Greer B., Swisher E., Paley P., Mandel L., et al. The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol. Oncol. 90 (2003) 150-157
42. Fader A.N., Michener C.M., Giannios N., Frasure H., Belinson J.L., and Zanotti K.M. Total laparoscopic hysterectomy versus laparoscopic-assisted vaginal hysterectomy in endometrial cancer: surgical and survival outcomes. J. Min. Inv. Gynecol. (2009) May
43. Gehrig P.A., Cantrell L.A., Shafer A., Abaid L.N., Mendivil A., and Boggess J. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?. Gynecol. Oncol. 111 (2008) 41-45
44. J. L. Walker, M. Piedmonte, N. Spirtos, S. Eisenkop, J. Schlaerth, R. S. Mannel, et al. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 5010.
45. Berchuck A., Anspach C., Evans A.C., et al. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol. Oncol. 59 (1995) 20-22
46. Reddoch J.M., Burke T.W., Morris M., et al. Surveillance for recurrent endometrial carcinoma: development of a follow-upscheme. Gynecol. Oncol. 59 (1995) 221-225
47. Norman S.A., Potashnik H.L., and Galantino H.L. Modifiable risk factors for breast cancer recurrence: what can we tell survivors?. J. Womens Health (Larchmt). 16 (2007) 177-190
48. Demark-Wahnifried W. Riding the crest of the teachable moment: promoting long term health after the diagnosis of cancer. J. Clin. Oncol. 23 (2005) 5814-5830
49. Tuthill A., Quinn A., McColgan D., McKenna M., O'Shea D., and McKenna T.J. A prospective randomized controlled trial of lifestyle intervention on quality of life and cardiovascular risk score in patients with obesity and type 2 diabetes. Diabetes Obese. Metab. 9 (2007) 917-919
50. Beesley E.a.k.i.n.E.G., Janda M., and Battistuttta D. Gynecological cancer survivors' health behaviors and their associations with quality of life. Cancer Causes Control 19 (2008) 775-782
51. Blanchard C.M., Courneya K.S., and Stein K. American Cancer Society's SCS-II. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J. Clin. Oncol. 26 (2008) 04-2198
52. Gil K.M., Gibbons H.E., Jenison E.L., Hopkins M.P., and von Gruenigen V.E. Baseline characteristics influencing quality of life in women undergoing gynecologic oncology surgery. Health Qual. Life Outcomes 5 (2007 May) 25
53. Courneya K.S., Karvinen K.H., Campbell K.L., Pearcey R.G., Dundas G., Capstick V., et al. Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. Gynecol. Oncol. 97 (2005) 422-430
54. von Gruenigen V.E., Gil K.M., Frasure H.E., Grandon M., Hopkins M.P., and Jenison E.L. Complementary medicine use, diet and exercise in endometrial cancer survivors. J. Cancer Integrative Medicine 3 (2005) 3-18
55. von Gruenigen V.E., Courneya K.C., Gibbons H.E., Kavanagh M.B., Waggoner S.E., and Lerner E. Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial. Gynecol. Oncol. 109 (2008) 19-26
56. Fader A.N., Gil K., Gibbons H., and von Gruenigen V.E. Focused Plenary, Endometrial cancer, Annual Meeting on Women's Cancers, SGO (2008)